Loading...
XNAS
SGRY
Market cap2.19bUSD
Jul 09, Last price  
16.77USD
1D
1.64%
1Q
29.90%
Jan 2017
5.80%
IPO
-9.01%
Name

Surgery Partners Inc

Chart & Performance

D1W1MN
XNAS:SGRY chart
P/E
P/S
0.66
EPS
Div Yield, %
Shrs. gr., 5y
21.13%
Rev. gr., 5y
12.21%
Revenues
3.31b
+6.24%
260,215,000284,599,000403,289,000959,891,0001,145,438,0001,341,219,0001,771,456,0001,831,400,0001,860,100,0002,225,100,0002,539,300,0002,743,300,0003,114,300,0003,308,700,000
Net income
-78m
L-53.66%
1,916,000-9,062,000-65,897,0001,429,0009,453,000-52,985,000-205,706,000-74,800,000-116,100,000-70,900,000-54,600,000-11,900,000-168,100,000-77,900,000
CFO
274m
-8.60%
46,377,00049,078,00021,949,00084,481,000125,239,000120,943,000144,600,000129,500,000246,900,00087,100,000158,800,000293,800,000300,100,000274,300,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
IPO date
Oct 01, 2015
Employees
9,100
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT